New products July 2008 Rx NEW DOSAGE The FDA has approved a new once-a-month dose of Actonel (risedronate sodium) tablets at 150 mg.The medication for the treatment and prevention of postmenopausal osteoporosis is approved to reduce the risk of fractures in...
Research and Markets: Warner Chilcott Ltd has a Strong Portfolio of Marketed and Pipeline Products Specialisin - Research and Markets (http://www.researchandmarkets.com/reports/c94183) has announced the addition of 'Warner Chilcott Ltd: Premium Company Profile' to their offering.Warner Chilcott is a specialty pharmaceutical company focused on two...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an online survey completed by...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an online...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis According to the study, the majority of Dermatologists reported an increase in their use of biologics for the treatment of psoriasis in the past year, particularly in patients with moderate psoriasis.While the increased use of biologics...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis EXTON, Pa., June 5 PA-BioTrends-psriasis EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an online...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis According to the study, the majority of Dermatologists reported an increase in their use of biologics for the treatment of psoriasis in the past year, particularly in patients with moderate psoriasis.While the increased use of biologics...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis PM EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an online...
Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc.released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis.
This report is based on responses to an online...
US FDA approves topical combo for psoriasis Warner Chilcott and LEO Pharma announced that the United States Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Taclonex Scalp (calcipotriene 0.005 per cent and betamethasone dipropionate 0.064%)...
